小艾财税网是由小艾财税科技公司全新打造的企业财税综合云服务平台,提供财税一体化的小艾财税通系统和电子政务浏览器软件,可以一键报税、一键批量零申报、一键批量打印、一键财税风险扫描,可以在线财税课程学习,及时掌握最新财税政策法规和财税最新动态;小艾财税网在线提供行业协会推荐的优质企业服务商,提供财务代账、证照办理、报表审计、社保代办、审计评估、工程造价、法律服务、司法鉴定等企业综合服务,小艾财税是您值得信赖的财税顾问!
江苏金旺新材料科技有限公司是一家专注于印字胶带,半成品母卷,水性压敏胶水的公司,印字胶带,半成品母卷,水性压敏胶水深受客户喜爱
丁华律师,专注于提供昆山地区权威的强制执行法律服务。在昆山,无论是面临财产保全还是执行难的问题,我们都能为您提供专业的法律咨询和诉讼代理服务。强制执行程序、债务追讨、资产追踪与冻结等。
旭腾人力旭腾
1桶水是专注于桶装水配送、批发,全国多家水站连锁的电商品牌,线上下单,2小时内送达。订水、送水、买桶装水、大桶水、农夫山泉桶装水、娃哈哈、景田桶装水就选1桶水(一桶水),质量保证,假一赔十!1桶水,千万用户的送水邻居。
天地华宇-黑龙江省五洲华宇恒业物流有限公司全国550个大中城市拥有56个货物中转枢纽、1250个营业网点、1200条长途运输干线,联系电话021-60916666/!
暂无描述...
Red1Karting是北京地区乃至全国首家真正与世界同步的室内外综合性一体化卡丁车运营机构(中国首条CIK-FIA认证国际级专业卡丁车赛道,中国首次室内车场+室外赛道的形式)将娱乐、竞技、餐饮、休闲等多项功能集于一身。前台咨询:010-64306688,市场及大客户业务:010-64306690
WestVacBiopharmaisfoundedbyAcademicianWeiYuquanfromWestChinaHospitalofSichuanUniversity,togetherwith10scientistsfromStateKeyLaboratoryofBiotherapy(SKLB).ItsheadquarterislocatedintheInternationalBio-Town,Chengdu.TheCEOofWestVacBiopharmaisProf.WeiYuquan,whoistheAcademicianofChineseAcademyofSciencesaswellastheDirectorofStateKeyLaboratoryofBiotherapy.WestVaciscommittedtoexploringthelatestbiotherapytechnologiesformajordiseases,includinginfectiousdiseases,malignanttumors,cardiovasculardiseases,andsoon.IthasattachedgreatimportanceintheResearchandDevelopment(R&D)ofCOVID-19vaccineespeciallyandbuildingaCOVID-19vaccineproductionplatform.StateKeyLaboratoryofBiotherapy(SKLB)wasestablishedbytheMinistryofSciencesandTechnologyofChinain2005andbecameoneoftheNationalR&DPlatformsforNovelDrugsfoundedbytheMinistriesofSciencesandTechnologyaswellasthatofHealthofChinain2008.ItisalsosupportedbyNationalCollaborativeInnovationProgramandhasbecometheNationalCollaborativeInnovationCenterforBiotherapysince2013.WestChinaHospitalofSichuanUniversity,foundedin1892,istheNationalCenterforDiagnosisandTreatmentofSevereandCriticalDiseasesinWesternChina.Itisalsotheworld’slargestcomprehensivehospitalcomplexlocatedinonecampusarea.RelyingonthemedicalresourcesofStateKeyLaboratoryofBiotherapyandWestChinaMedicalCenter,WestVachasadoptedrecombinantproteinmethodologytodeveloptheCOVID-19vaccine.Becauseofthesafetyoftheproteinvaccine,itisalsotheonlyCOVID-19vaccineapprovedfortheuseinchildrenover3yearsoldinChina.ThevaccinewasapprovedbytheNationalMedicalProductsAdministrationforclinicaltrialsonAugust21,2020.PhaseI/IIclinicaltrialshavebeencompleted,andphaseIIIclinicaltrialsarebeingcarriedoutinNepal,Kenya,Japanandothercountries.Thevaccinetargetsthespikeproteinbindingdomain(S-RBD)ofSARS-CoV-2,producingneutralizingantibodiestoblockCOVID-19infectionofhumancells.TheresultwaspublishedonNature,theworld’sfamousscientificjournalonJuly29th,2020.IthasalsobeenthefirstpaperofCOVIDvaccinepublishedbyNaturesincethepandemicoutbreak.TheS-RBDgeneoftheCOVID-19virusisintroducedintotheinsectcells,whichwereusedasafactorytoproducehigh-qualityrecombinantvaccineproteinandthendoesrefinedpurification.Suchtechnologyiseasytobemass-producedandbroughttothemarket.WestVacBiopharmaiscommittedtobecomingtheworld`sleadingvaccineandimmunotherapyplatform.